Shares of Regeneron Pharmaceuticals, Inc. (REGN) are falling about 6 percent during Wednesday morning trading, after the company announced a decline in its first-quarter earnings to $727.2 million, or $6.75 per share, from last year's $808.7 million, or $7.27 per share.
The company's stock is currently trading at $683.59, down 6.58 percent or $48.18, over the previous close of $731.77 on the Nasdaq. It has traded between $476.49 and $821.11 in the past one year.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.